nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—SLCO1B3—Docetaxel—melanoma	0.331	0.662	CbGbCtD
Gadoxetate—ABCC2—Docetaxel—melanoma	0.17	0.339	CbGbCtD
Gadoxetate—Gadofosveset trisodium—ALB—melanoma	0.0044	1	CrCbGaD
Gadoxetate—Connective tissue disorder—Vemurafenib—melanoma	0.00216	0.0067	CcSEcCtD
Gadoxetate—Disorientation—Bleomycin—melanoma	0.00215	0.00668	CcSEcCtD
Gadoxetate—Sepsis—Dactinomycin—melanoma	0.00214	0.00666	CcSEcCtD
Gadoxetate—Phlebitis—Dactinomycin—melanoma	0.00208	0.00647	CcSEcCtD
Gadoxetate—Cardiac disorder—Vemurafenib—melanoma	0.00204	0.00633	CcSEcCtD
Gadoxetate—Sepsis—Carmustine—melanoma	0.002	0.00624	CcSEcCtD
Gadoxetate—Angiopathy—Vemurafenib—melanoma	0.00199	0.00619	CcSEcCtD
Gadoxetate—Mediastinal disorder—Vemurafenib—melanoma	0.00198	0.00615	CcSEcCtD
Gadoxetate—Chills—Vemurafenib—melanoma	0.00197	0.00612	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Bleomycin—melanoma	0.00196	0.0061	CcSEcCtD
Gadoxetate—Phlebitis—Carmustine—melanoma	0.00195	0.00605	CcSEcCtD
Gadoxetate—Swelling—Carmustine—melanoma	0.0019	0.00591	CcSEcCtD
Gadoxetate—Necrosis—Docetaxel—melanoma	0.00189	0.00588	CcSEcCtD
Gadoxetate—Dysgeusia—Vemurafenib—melanoma	0.00187	0.00582	CcSEcCtD
Gadoxetate—Back pain—Vemurafenib—melanoma	0.00185	0.00575	CcSEcCtD
Gadoxetate—Extravasation—Docetaxel—melanoma	0.0017	0.00529	CcSEcCtD
Gadoxetate—Cough—Vemurafenib—melanoma	0.00167	0.00518	CcSEcCtD
Gadoxetate—Bronchospasm—Bleomycin—melanoma	0.00163	0.00508	CcSEcCtD
Gadoxetate—Face oedema—Carmustine—melanoma	0.00162	0.00504	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00161	0.00502	CcSEcCtD
Gadoxetate—Oliguria—Docetaxel—melanoma	0.00161	0.00501	CcSEcCtD
Gadoxetate—Face oedema—Temozolomide—melanoma	0.00156	0.00487	CcSEcCtD
Gadoxetate—Anaphylactic shock—Vemurafenib—melanoma	0.00156	0.00485	CcSEcCtD
Gadoxetate—Dysphagia—Dactinomycin—melanoma	0.00155	0.00482	CcSEcCtD
Gadoxetate—Infection—Vemurafenib—melanoma	0.00155	0.00482	CcSEcCtD
Gadoxetate—Nervous system disorder—Vemurafenib—melanoma	0.00153	0.00475	CcSEcCtD
Gadoxetate—Hypokalaemia—Carmustine—melanoma	0.00153	0.00475	CcSEcCtD
Gadoxetate—Skin disorder—Vemurafenib—melanoma	0.00151	0.00471	CcSEcCtD
Gadoxetate—Dehydration—Temozolomide—melanoma	0.00151	0.00469	CcSEcCtD
Gadoxetate—Blood pressure increased—Docetaxel—melanoma	0.00148	0.00462	CcSEcCtD
Gadoxetate—Injection site reaction—Docetaxel—melanoma	0.00148	0.00459	CcSEcCtD
Gadoxetate—Hypokalaemia—Temozolomide—melanoma	0.00147	0.00459	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Bleomycin—melanoma	0.00146	0.00454	CcSEcCtD
Gadoxetate—Hypotension—Vemurafenib—melanoma	0.00146	0.00453	CcSEcCtD
Gadoxetate—Myocardial infarction—Bleomycin—melanoma	0.00145	0.00451	CcSEcCtD
Gadoxetate—Dysphagia—Carmustine—melanoma	0.00145	0.00451	CcSEcCtD
Gadoxetate—Abdominal distension—Temozolomide—melanoma	0.00141	0.00439	CcSEcCtD
Gadoxetate—Fluid retention—Docetaxel—melanoma	0.00141	0.00438	CcSEcCtD
Gadoxetate—Dysphagia—Temozolomide—melanoma	0.0014	0.00436	CcSEcCtD
Gadoxetate—Sweating increased—Temozolomide—melanoma	0.00136	0.00424	CcSEcCtD
Gadoxetate—Decreased appetite—Vemurafenib—melanoma	0.00135	0.00421	CcSEcCtD
Gadoxetate—Bronchitis—Temozolomide—melanoma	0.00135	0.00419	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Vemurafenib—melanoma	0.00135	0.00418	CcSEcCtD
Gadoxetate—Fatigue—Vemurafenib—melanoma	0.00134	0.00418	CcSEcCtD
Gadoxetate—Constipation—Vemurafenib—melanoma	0.00133	0.00415	CcSEcCtD
Gadoxetate—Lightheadedness—Docetaxel—melanoma	0.00133	0.00413	CcSEcCtD
Gadoxetate—Hypoaesthesia—Bleomycin—melanoma	0.00132	0.00411	CcSEcCtD
Gadoxetate—Sepsis—Docetaxel—melanoma	0.00129	0.00401	CcSEcCtD
Gadoxetate—Renal failure—Carmustine—melanoma	0.00127	0.00395	CcSEcCtD
Gadoxetate—Phlebitis—Docetaxel—melanoma	0.00125	0.00389	CcSEcCtD
Gadoxetate—Flushing—Bleomycin—melanoma	0.00123	0.00384	CcSEcCtD
Gadoxetate—Body temperature increased—Vemurafenib—melanoma	0.00123	0.00383	CcSEcCtD
Gadoxetate—Swelling—Docetaxel—melanoma	0.00122	0.0038	CcSEcCtD
Gadoxetate—Chills—Bleomycin—melanoma	0.00119	0.00371	CcSEcCtD
Gadoxetate—Cardiac failure congestive—Docetaxel—melanoma	0.00119	0.0037	CcSEcCtD
Gadoxetate—Hypoaesthesia—Carmustine—melanoma	0.00115	0.00359	CcSEcCtD
Gadoxetate—Flushing—Dactinomycin—melanoma	0.00115	0.00358	CcSEcCtD
Gadoxetate—Hypersensitivity—Vemurafenib—melanoma	0.00115	0.00357	CcSEcCtD
Gadoxetate—Connective tissue disorder—Carmustine—melanoma	0.00114	0.00355	CcSEcCtD
Gadoxetate—Renal impairment—Docetaxel—melanoma	0.00113	0.00352	CcSEcCtD
Gadoxetate—Asthenia—Vemurafenib—melanoma	0.00112	0.00348	CcSEcCtD
Gadoxetate—Hypoaesthesia—Temozolomide—melanoma	0.00112	0.00347	CcSEcCtD
Gadoxetate—Chills—Dactinomycin—melanoma	0.00111	0.00346	CcSEcCtD
Gadoxetate—Pruritus—Vemurafenib—melanoma	0.0011	0.00343	CcSEcCtD
Gadoxetate—Connective tissue disorder—Temozolomide—melanoma	0.0011	0.00343	CcSEcCtD
Gadoxetate—Flushing—Carmustine—melanoma	0.00108	0.00335	CcSEcCtD
Gadoxetate—Ill-defined disorder—Bleomycin—melanoma	0.00107	0.00334	CcSEcCtD
Gadoxetate—Diarrhoea—Vemurafenib—melanoma	0.00107	0.00332	CcSEcCtD
Gadoxetate—Malaise—Bleomycin—melanoma	0.00104	0.00324	CcSEcCtD
Gadoxetate—Flushing—Temozolomide—melanoma	0.00104	0.00324	CcSEcCtD
Gadoxetate—Cardiac disorder—Temozolomide—melanoma	0.00104	0.00324	CcSEcCtD
Gadoxetate—Arrhythmia—Carmustine—melanoma	0.00104	0.00322	CcSEcCtD
Gadoxetate—Dizziness—Vemurafenib—melanoma	0.00103	0.00321	CcSEcCtD
Gadoxetate—Angiopathy—Temozolomide—melanoma	0.00102	0.00316	CcSEcCtD
Gadoxetate—Immune system disorder—Temozolomide—melanoma	0.00101	0.00315	CcSEcCtD
Gadoxetate—Mediastinal disorder—Temozolomide—melanoma	0.00101	0.00314	CcSEcCtD
Gadoxetate—Cough—Bleomycin—melanoma	0.00101	0.00314	CcSEcCtD
Gadoxetate—Chills—Temozolomide—melanoma	0.00101	0.00313	CcSEcCtD
Gadoxetate—Dehydration—Docetaxel—melanoma	0.001	0.00312	CcSEcCtD
Gadoxetate—Ill-defined disorder—Dactinomycin—melanoma	0.001	0.00311	CcSEcCtD
Gadoxetate—Vomiting—Vemurafenib—melanoma	0.000991	0.00308	CcSEcCtD
Gadoxetate—Chest pain—Bleomycin—melanoma	0.000985	0.00306	CcSEcCtD
Gadoxetate—Rash—Vemurafenib—melanoma	0.000983	0.00306	CcSEcCtD
Gadoxetate—Dermatitis—Vemurafenib—melanoma	0.000982	0.00305	CcSEcCtD
Gadoxetate—Back pain—Carmustine—melanoma	0.000977	0.00304	CcSEcCtD
Gadoxetate—Headache—Vemurafenib—melanoma	0.000976	0.00304	CcSEcCtD
Gadoxetate—Discomfort—Bleomycin—melanoma	0.000973	0.00303	CcSEcCtD
Gadoxetate—Malaise—Dactinomycin—melanoma	0.000973	0.00303	CcSEcCtD
Gadoxetate—Dysgeusia—Temozolomide—melanoma	0.000956	0.00297	CcSEcCtD
Gadoxetate—Vision blurred—Carmustine—melanoma	0.000952	0.00296	CcSEcCtD
Gadoxetate—Tremor—Carmustine—melanoma	0.000946	0.00294	CcSEcCtD
Gadoxetate—Oedema—Bleomycin—melanoma	0.000944	0.00294	CcSEcCtD
Gadoxetate—Anaphylactic shock—Bleomycin—melanoma	0.000944	0.00294	CcSEcCtD
Gadoxetate—Back pain—Temozolomide—melanoma	0.000944	0.00294	CcSEcCtD
Gadoxetate—Infection—Bleomycin—melanoma	0.000938	0.00292	CcSEcCtD
Gadoxetate—Dysphagia—Docetaxel—melanoma	0.000931	0.0029	CcSEcCtD
Gadoxetate—Agitation—Carmustine—melanoma	0.000928	0.00289	CcSEcCtD
Gadoxetate—Nausea—Vemurafenib—melanoma	0.000926	0.00288	CcSEcCtD
Gadoxetate—Vision blurred—Temozolomide—melanoma	0.00092	0.00286	CcSEcCtD
Gadoxetate—Bronchospasm—Docetaxel—melanoma	0.000916	0.00285	CcSEcCtD
Gadoxetate—Tremor—Temozolomide—melanoma	0.000914	0.00284	CcSEcCtD
Gadoxetate—Discomfort—Dactinomycin—melanoma	0.000907	0.00282	CcSEcCtD
Gadoxetate—Ill-defined disorder—Temozolomide—melanoma	0.000905	0.00282	CcSEcCtD
Gadoxetate—Anorexia—Bleomycin—melanoma	0.0009	0.0028	CcSEcCtD
Gadoxetate—Agitation—Temozolomide—melanoma	0.000897	0.00279	CcSEcCtD
Gadoxetate—Hypotension—Bleomycin—melanoma	0.000882	0.00274	CcSEcCtD
Gadoxetate—Oedema—Dactinomycin—melanoma	0.00088	0.00274	CcSEcCtD
Gadoxetate—Malaise—Temozolomide—melanoma	0.00088	0.00274	CcSEcCtD
Gadoxetate—Vertigo—Temozolomide—melanoma	0.000877	0.00273	CcSEcCtD
Gadoxetate—Convulsion—Carmustine—melanoma	0.000875	0.00272	CcSEcCtD
Gadoxetate—Infection—Dactinomycin—melanoma	0.000875	0.00272	CcSEcCtD
Gadoxetate—Palpitations—Temozolomide—melanoma	0.000862	0.00268	CcSEcCtD
Gadoxetate—Chest pain—Carmustine—melanoma	0.00086	0.00267	CcSEcCtD
Gadoxetate—Anxiety—Carmustine—melanoma	0.000857	0.00266	CcSEcCtD
Gadoxetate—Cough—Temozolomide—melanoma	0.000852	0.00265	CcSEcCtD
Gadoxetate—Paraesthesia—Bleomycin—melanoma	0.000848	0.00264	CcSEcCtD
Gadoxetate—Convulsion—Temozolomide—melanoma	0.000845	0.00263	CcSEcCtD
Gadoxetate—Dyspnoea—Bleomycin—melanoma	0.000842	0.00262	CcSEcCtD
Gadoxetate—Anorexia—Dactinomycin—melanoma	0.000839	0.00261	CcSEcCtD
Gadoxetate—Anxiety—Temozolomide—melanoma	0.000828	0.00258	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000825	0.00257	CcSEcCtD
Gadoxetate—Oedema—Carmustine—melanoma	0.000824	0.00256	CcSEcCtD
Gadoxetate—Discomfort—Temozolomide—melanoma	0.000821	0.00255	CcSEcCtD
Gadoxetate—Decreased appetite—Bleomycin—melanoma	0.000821	0.00255	CcSEcCtD
Gadoxetate—Infection—Carmustine—melanoma	0.000819	0.00255	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Docetaxel—melanoma	0.000819	0.00255	CcSEcCtD
Gadoxetate—Renal failure—Docetaxel—melanoma	0.000816	0.00254	CcSEcCtD
Gadoxetate—Myocardial infarction—Docetaxel—melanoma	0.000814	0.00253	CcSEcCtD
Gadoxetate—Dry mouth—Temozolomide—melanoma	0.000812	0.00253	CcSEcCtD
Gadoxetate—Conjunctivitis—Docetaxel—melanoma	0.000807	0.00251	CcSEcCtD
Gadoxetate—Tachycardia—Carmustine—melanoma	0.000804	0.0025	CcSEcCtD
Gadoxetate—Anaphylactic shock—Temozolomide—melanoma	0.000796	0.00248	CcSEcCtD
Gadoxetate—Oedema—Temozolomide—melanoma	0.000796	0.00248	CcSEcCtD
Gadoxetate—Infection—Temozolomide—melanoma	0.000791	0.00246	CcSEcCtD
Gadoxetate—Anorexia—Carmustine—melanoma	0.000786	0.00244	CcSEcCtD
Gadoxetate—Nervous system disorder—Temozolomide—melanoma	0.000781	0.00243	CcSEcCtD
Gadoxetate—Feeling abnormal—Bleomycin—melanoma	0.000778	0.00242	CcSEcCtD
Gadoxetate—Skin disorder—Temozolomide—melanoma	0.000774	0.00241	CcSEcCtD
Gadoxetate—Hypotension—Carmustine—melanoma	0.00077	0.0024	CcSEcCtD
Gadoxetate—Hyperhidrosis—Temozolomide—melanoma	0.00077	0.00239	CcSEcCtD
Gadoxetate—Decreased appetite—Dactinomycin—melanoma	0.000765	0.00238	CcSEcCtD
Gadoxetate—Fatigue—Dactinomycin—melanoma	0.000759	0.00236	CcSEcCtD
Gadoxetate—Anorexia—Temozolomide—melanoma	0.000759	0.00236	CcSEcCtD
Gadoxetate—Urticaria—Bleomycin—melanoma	0.00075	0.00233	CcSEcCtD
Gadoxetate—Rhinitis—Docetaxel—melanoma	0.000747	0.00232	CcSEcCtD
Gadoxetate—Body temperature increased—Bleomycin—melanoma	0.000746	0.00232	CcSEcCtD
Gadoxetate—Hypoaesthesia—Docetaxel—melanoma	0.000742	0.00231	CcSEcCtD
Gadoxetate—Paraesthesia—Carmustine—melanoma	0.00074	0.0023	CcSEcCtD
Gadoxetate—Dyspnoea—Carmustine—melanoma	0.000735	0.00229	CcSEcCtD
Gadoxetate—Connective tissue disorder—Docetaxel—melanoma	0.000733	0.00228	CcSEcCtD
Gadoxetate—Feeling abnormal—Dactinomycin—melanoma	0.000726	0.00226	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Dactinomycin—melanoma	0.00072	0.00224	CcSEcCtD
Gadoxetate—Decreased appetite—Carmustine—melanoma	0.000716	0.00223	CcSEcCtD
Gadoxetate—Paraesthesia—Temozolomide—melanoma	0.000715	0.00222	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Carmustine—melanoma	0.000711	0.00221	CcSEcCtD
Gadoxetate—Dyspnoea—Temozolomide—melanoma	0.00071	0.00221	CcSEcCtD
Gadoxetate—Constipation—Carmustine—melanoma	0.000705	0.00219	CcSEcCtD
Gadoxetate—Abdominal pain—Dactinomycin—melanoma	0.000696	0.00217	CcSEcCtD
Gadoxetate—Body temperature increased—Dactinomycin—melanoma	0.000696	0.00217	CcSEcCtD
Gadoxetate—Hypersensitivity—Bleomycin—melanoma	0.000696	0.00216	CcSEcCtD
Gadoxetate—Decreased appetite—Temozolomide—melanoma	0.000692	0.00215	CcSEcCtD
Gadoxetate—Flushing—Docetaxel—melanoma	0.000692	0.00215	CcSEcCtD
Gadoxetate—Cardiac disorder—Docetaxel—melanoma	0.000692	0.00215	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Temozolomide—melanoma	0.000688	0.00214	CcSEcCtD
Gadoxetate—Fatigue—Temozolomide—melanoma	0.000687	0.00214	CcSEcCtD
Gadoxetate—Constipation—Temozolomide—melanoma	0.000681	0.00212	CcSEcCtD
Gadoxetate—Feeling abnormal—Carmustine—melanoma	0.000679	0.00211	CcSEcCtD
Gadoxetate—Asthenia—Bleomycin—melanoma	0.000677	0.00211	CcSEcCtD
Gadoxetate—Angiopathy—Docetaxel—melanoma	0.000676	0.0021	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Carmustine—melanoma	0.000674	0.0021	CcSEcCtD
Gadoxetate—Immune system disorder—Docetaxel—melanoma	0.000673	0.00209	CcSEcCtD
Gadoxetate—Mediastinal disorder—Docetaxel—melanoma	0.000672	0.00209	CcSEcCtD
Gadoxetate—Chills—Docetaxel—melanoma	0.000669	0.00208	CcSEcCtD
Gadoxetate—Pruritus—Bleomycin—melanoma	0.000668	0.00208	CcSEcCtD
Gadoxetate—Arrhythmia—Docetaxel—melanoma	0.000666	0.00207	CcSEcCtD
Gadoxetate—Feeling abnormal—Temozolomide—melanoma	0.000656	0.00204	CcSEcCtD
Gadoxetate—Abdominal pain—Carmustine—melanoma	0.000651	0.00203	CcSEcCtD
Gadoxetate—Body temperature increased—Carmustine—melanoma	0.000651	0.00203	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Temozolomide—melanoma	0.000651	0.00203	CcSEcCtD
Gadoxetate—Hypersensitivity—Dactinomycin—melanoma	0.000649	0.00202	CcSEcCtD
Gadoxetate—Dysgeusia—Docetaxel—melanoma	0.000635	0.00198	CcSEcCtD
Gadoxetate—Urticaria—Temozolomide—melanoma	0.000633	0.00197	CcSEcCtD
Gadoxetate—Asthenia—Dactinomycin—melanoma	0.000632	0.00197	CcSEcCtD
Gadoxetate—Body temperature increased—Temozolomide—melanoma	0.00063	0.00196	CcSEcCtD
Gadoxetate—Abdominal pain—Temozolomide—melanoma	0.00063	0.00196	CcSEcCtD
Gadoxetate—Back pain—Docetaxel—melanoma	0.000628	0.00195	CcSEcCtD
Gadoxetate—Hypersensitivity—Carmustine—melanoma	0.000607	0.00189	CcSEcCtD
Gadoxetate—Diarrhoea—Dactinomycin—melanoma	0.000602	0.00187	CcSEcCtD
Gadoxetate—Vomiting—Bleomycin—melanoma	0.0006	0.00187	CcSEcCtD
Gadoxetate—Rash—Bleomycin—melanoma	0.000595	0.00185	CcSEcCtD
Gadoxetate—Dermatitis—Bleomycin—melanoma	0.000595	0.00185	CcSEcCtD
Gadoxetate—Asthenia—Carmustine—melanoma	0.000591	0.00184	CcSEcCtD
Gadoxetate—Hypersensitivity—Temozolomide—melanoma	0.000587	0.00183	CcSEcCtD
Gadoxetate—Syncope—Docetaxel—melanoma	0.000582	0.00181	CcSEcCtD
Gadoxetate—Palpitations—Docetaxel—melanoma	0.000573	0.00178	CcSEcCtD
Gadoxetate—Asthenia—Temozolomide—melanoma	0.000571	0.00178	CcSEcCtD
Gadoxetate—Loss of consciousness—Docetaxel—melanoma	0.00057	0.00177	CcSEcCtD
Gadoxetate—Cough—Docetaxel—melanoma	0.000566	0.00176	CcSEcCtD
Gadoxetate—Diarrhoea—Carmustine—melanoma	0.000564	0.00175	CcSEcCtD
Gadoxetate—Pruritus—Temozolomide—melanoma	0.000563	0.00175	CcSEcCtD
Gadoxetate—Convulsion—Docetaxel—melanoma	0.000562	0.00175	CcSEcCtD
Gadoxetate—Nausea—Bleomycin—melanoma	0.000561	0.00174	CcSEcCtD
Gadoxetate—Vomiting—Dactinomycin—melanoma	0.00056	0.00174	CcSEcCtD
Gadoxetate—Rash—Dactinomycin—melanoma	0.000555	0.00173	CcSEcCtD
Gadoxetate—Chest pain—Docetaxel—melanoma	0.000552	0.00172	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000549	0.00171	CcSEcCtD
Gadoxetate—Dizziness—Carmustine—melanoma	0.000545	0.0017	CcSEcCtD
Gadoxetate—Diarrhoea—Temozolomide—melanoma	0.000545	0.00169	CcSEcCtD
Gadoxetate—Dry mouth—Docetaxel—melanoma	0.00054	0.00168	CcSEcCtD
Gadoxetate—Oedema—Docetaxel—melanoma	0.00053	0.00165	CcSEcCtD
Gadoxetate—Anaphylactic shock—Docetaxel—melanoma	0.00053	0.00165	CcSEcCtD
Gadoxetate—Dizziness—Temozolomide—melanoma	0.000527	0.00164	CcSEcCtD
Gadoxetate—Infection—Docetaxel—melanoma	0.000526	0.00164	CcSEcCtD
Gadoxetate—Vomiting—Carmustine—melanoma	0.000524	0.00163	CcSEcCtD
Gadoxetate—Nausea—Dactinomycin—melanoma	0.000523	0.00163	CcSEcCtD
Gadoxetate—Shock—Docetaxel—melanoma	0.000521	0.00162	CcSEcCtD
Gadoxetate—Rash—Carmustine—melanoma	0.00052	0.00162	CcSEcCtD
Gadoxetate—Nervous system disorder—Docetaxel—melanoma	0.000519	0.00162	CcSEcCtD
Gadoxetate—Dermatitis—Carmustine—melanoma	0.000519	0.00161	CcSEcCtD
Gadoxetate—Tachycardia—Docetaxel—melanoma	0.000517	0.00161	CcSEcCtD
Gadoxetate—Headache—Carmustine—melanoma	0.000516	0.00161	CcSEcCtD
Gadoxetate—Skin disorder—Docetaxel—melanoma	0.000514	0.0016	CcSEcCtD
Gadoxetate—Vomiting—Temozolomide—melanoma	0.000506	0.00158	CcSEcCtD
Gadoxetate—Anorexia—Docetaxel—melanoma	0.000505	0.00157	CcSEcCtD
Gadoxetate—Rash—Temozolomide—melanoma	0.000502	0.00156	CcSEcCtD
Gadoxetate—Dermatitis—Temozolomide—melanoma	0.000502	0.00156	CcSEcCtD
Gadoxetate—Headache—Temozolomide—melanoma	0.000499	0.00155	CcSEcCtD
Gadoxetate—Hypotension—Docetaxel—melanoma	0.000495	0.00154	CcSEcCtD
Gadoxetate—Nausea—Carmustine—melanoma	0.00049	0.00152	CcSEcCtD
Gadoxetate—Paraesthesia—Docetaxel—melanoma	0.000476	0.00148	CcSEcCtD
Gadoxetate—Nausea—Temozolomide—melanoma	0.000473	0.00147	CcSEcCtD
Gadoxetate—Dyspnoea—Docetaxel—melanoma	0.000472	0.00147	CcSEcCtD
Gadoxetate—Decreased appetite—Docetaxel—melanoma	0.00046	0.00143	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Docetaxel—melanoma	0.000457	0.00142	CcSEcCtD
Gadoxetate—Fatigue—Docetaxel—melanoma	0.000457	0.00142	CcSEcCtD
Gadoxetate—Constipation—Docetaxel—melanoma	0.000453	0.00141	CcSEcCtD
Gadoxetate—Feeling abnormal—Docetaxel—melanoma	0.000436	0.00136	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Docetaxel—melanoma	0.000433	0.00135	CcSEcCtD
Gadoxetate—Body temperature increased—Docetaxel—melanoma	0.000419	0.0013	CcSEcCtD
Gadoxetate—Abdominal pain—Docetaxel—melanoma	0.000419	0.0013	CcSEcCtD
Gadoxetate—Hypersensitivity—Docetaxel—melanoma	0.00039	0.00121	CcSEcCtD
Gadoxetate—Asthenia—Docetaxel—melanoma	0.00038	0.00118	CcSEcCtD
Gadoxetate—Pruritus—Docetaxel—melanoma	0.000375	0.00117	CcSEcCtD
Gadoxetate—Diarrhoea—Docetaxel—melanoma	0.000362	0.00113	CcSEcCtD
Gadoxetate—Dizziness—Docetaxel—melanoma	0.00035	0.00109	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000347	0.002	CbGpPWpGaD
Gadoxetate—Vomiting—Docetaxel—melanoma	0.000337	0.00105	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000335	0.00193	CbGpPWpGaD
Gadoxetate—Rash—Docetaxel—melanoma	0.000334	0.00104	CcSEcCtD
Gadoxetate—Dermatitis—Docetaxel—melanoma	0.000334	0.00104	CcSEcCtD
Gadoxetate—Headache—Docetaxel—melanoma	0.000332	0.00103	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—GNAQ—melanoma	0.000332	0.00191	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000324	0.00187	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000323	0.00186	CbGpPWpGaD
Gadoxetate—Nausea—Docetaxel—melanoma	0.000315	0.000979	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000313	0.0018	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—BSG—melanoma	0.000312	0.0018	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SYK—melanoma	0.000312	0.0018	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000311	0.0018	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT3—melanoma	0.000306	0.00177	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ACER3—melanoma	0.000305	0.00176	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000304	0.00175	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IFNA5—melanoma	0.000302	0.00174	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—HGF—melanoma	0.000299	0.00172	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—FLNA—melanoma	0.000293	0.00169	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000292	0.00169	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000292	0.00169	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000282	0.00163	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—UGT2B10—melanoma	0.000279	0.00161	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000279	0.00161	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000276	0.00159	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ACER3—melanoma	0.000275	0.00159	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000265	0.00153	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—CLU—melanoma	0.000265	0.00153	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HS3ST5—melanoma	0.00026	0.0015	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—RHOB—melanoma	0.00026	0.0015	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—VEGFA—melanoma	0.000254	0.00147	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—HGF—melanoma	0.000254	0.00147	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—UGT2B10—melanoma	0.000252	0.00145	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—CSF2—melanoma	0.000251	0.00145	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000249	0.00144	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—melanoma	0.000242	0.0014	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PRKCA—melanoma	0.000241	0.00139	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—ITGB3—melanoma	0.000241	0.00139	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000239	0.00138	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HS3ST5—melanoma	0.000234	0.00135	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000233	0.00134	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—RAC2—melanoma	0.000233	0.00134	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFC—melanoma	0.000229	0.00132	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—RAC1—melanoma	0.000223	0.00129	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000218	0.00126	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000209	0.00121	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ACER3—melanoma	0.000205	0.00118	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SPARC—melanoma	0.000201	0.00116	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—F2R—melanoma	0.000201	0.00116	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—FN1—melanoma	0.000197	0.00114	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PLCB4—melanoma	0.000197	0.00114	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000193	0.00111	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—melanoma	0.000189	0.00109	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000188	0.00109	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HSPA5—melanoma	0.000188	0.00109	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—UGT2B10—melanoma	0.000188	0.00108	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—CTNNB1—melanoma	0.000187	0.00108	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—EGF—melanoma	0.000187	0.00108	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000185	0.00107	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIP4K2A—melanoma	0.000185	0.00107	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC6A11—melanoma	0.000185	0.00107	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—GNA11—melanoma	0.000184	0.00106	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—GAB2—melanoma	0.000184	0.00106	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000181	0.00104	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—MTAP—melanoma	0.00018	0.00104	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PLCB4—melanoma	0.000177	0.00102	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000176	0.00101	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HS3ST5—melanoma	0.000174	0.00101	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000174	0.00101	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HDAC2—melanoma	0.000173	0.000997	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—IGF1—melanoma	0.000173	0.000997	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—GNAQ—melanoma	0.000171	0.000986	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ITGA4—melanoma	0.000171	0.000986	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—CD44—melanoma	0.000171	0.000986	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IFNB1—melanoma	0.00017	0.000979	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—ALB—melanoma	0.000169	0.000978	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC6A11—melanoma	0.000167	0.000963	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIP4K2A—melanoma	0.000167	0.000963	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—melanoma	0.000166	0.000957	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IFNA1—melanoma	0.000166	0.000955	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—ALB—melanoma	0.000164	0.000945	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000163	0.00094	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—MTAP—melanoma	0.000162	0.000937	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SYK—melanoma	0.000161	0.000927	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PHGDH—melanoma	0.00016	0.000925	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—LUM—melanoma	0.00016	0.000925	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000159	0.000916	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ITGAV—melanoma	0.000158	0.00091	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT3—melanoma	0.000158	0.00091	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HPSE—melanoma	0.000157	0.000907	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CUBN—melanoma	0.000154	0.000891	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IFNA2—melanoma	0.000154	0.000889	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000153	0.000884	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—MYC—melanoma	0.000151	0.000873	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SDHD—melanoma	0.000149	0.00086	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CSPG4—melanoma	0.000149	0.00086	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—BSG—melanoma	0.000149	0.00086	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PHGDH—melanoma	0.000145	0.000835	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—LUM—melanoma	0.000145	0.000835	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—melanoma	0.000145	0.000834	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GPAM—melanoma	0.000144	0.000833	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ITGB1—melanoma	0.000143	0.000826	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HPSE—melanoma	0.000142	0.000819	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.00014	0.00081	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CUBN—melanoma	0.000139	0.000804	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ABCB1—melanoma	0.000138	0.000795	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CSPG4—melanoma	0.000135	0.000776	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SDHD—melanoma	0.000135	0.000776	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—BSG—melanoma	0.000135	0.000776	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—IL2—melanoma	0.000133	0.000766	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PLCB4—melanoma	0.000132	0.000763	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HGF—melanoma	0.000131	0.000756	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GPAM—melanoma	0.00013	0.000752	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—melanoma	0.00013	0.000749	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—CSF2—melanoma	0.00013	0.000747	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000129	0.000745	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIP4K2A—melanoma	0.000124	0.000717	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC6A11—melanoma	0.000124	0.000717	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ABCB1—melanoma	0.000124	0.000717	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ITGB3—melanoma	0.000124	0.000717	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PRKCA—melanoma	0.000124	0.000717	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PLA2G6—melanoma	0.000123	0.000708	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000121	0.0007	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—MTAP—melanoma	0.000121	0.000698	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000118	0.000682	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ABCB1—melanoma	0.000117	0.000674	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—RAC1—melanoma	0.000115	0.000664	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—ALB—melanoma	0.000114	0.000657	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—melanoma	0.000113	0.000651	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MMP1—melanoma	0.000111	0.000643	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PLA2G6—melanoma	0.000111	0.000639	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—VCAN—melanoma	0.00011	0.000636	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—CDK2—melanoma	0.000109	0.000631	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PHGDH—melanoma	0.000108	0.000622	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—LUM—melanoma	0.000108	0.000622	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—MAPK3—melanoma	0.000107	0.000616	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HPSE—melanoma	0.000106	0.00061	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000104	0.000602	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CUBN—melanoma	0.000104	0.000598	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—FN1—melanoma	0.000102	0.000587	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—MAPK1—melanoma	0.000102	0.000586	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000101	0.000581	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NOS2—melanoma	0.0001	0.00058	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CSPG4—melanoma	0.0001	0.000578	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—BSG—melanoma	0.0001	0.000578	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SDHD—melanoma	0.0001	0.000578	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—VCAN—melanoma	9.95e-05	0.000574	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ABCB1—melanoma	9.85e-05	0.000568	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CG—melanoma	9.73e-05	0.000561	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GPAM—melanoma	9.7e-05	0.00056	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—EGF—melanoma	9.61e-05	0.000555	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.42e-05	0.000543	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP17A1—melanoma	9.3e-05	0.000537	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ABCB1—melanoma	9.25e-05	0.000534	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.18e-05	0.00053	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.09e-05	0.000525	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—melanoma	9.06e-05	0.000523	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IGF1—melanoma	8.91e-05	0.000514	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—melanoma	8.81e-05	0.000509	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GNA11—melanoma	8.79e-05	0.000507	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ALB—melanoma	8.61e-05	0.000497	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—FASN—melanoma	8.6e-05	0.000496	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CD—melanoma	8.55e-05	0.000493	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC5A5—melanoma	8.46e-05	0.000488	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ALB—melanoma	8.44e-05	0.000487	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP17A1—melanoma	8.39e-05	0.000484	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.28e-05	0.000478	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PLA2G6—melanoma	8.25e-05	0.000476	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—ALB—melanoma	8.17e-05	0.000472	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GNAQ—melanoma	8.17e-05	0.000471	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CD44—melanoma	8.17e-05	0.000471	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8e-05	0.000462	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GNA11—melanoma	7.93e-05	0.000457	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.92e-05	0.000457	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP1B1—melanoma	7.83e-05	0.000452	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ALB—melanoma	7.77e-05	0.000448	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—FASN—melanoma	7.76e-05	0.000448	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC5A5—melanoma	7.63e-05	0.00044	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CB—melanoma	7.45e-05	0.00043	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—VCAN—melanoma	7.41e-05	0.000428	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GNAQ—melanoma	7.37e-05	0.000425	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CD44—melanoma	7.37e-05	0.000425	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ALB—melanoma	7.31e-05	0.000422	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.22e-05	0.000416	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT1—melanoma	7.2e-05	0.000416	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.15e-05	0.000413	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP1B1—melanoma	7.07e-05	0.000408	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.01e-05	0.000405	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.91e-05	0.000399	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IL2—melanoma	6.84e-05	0.000395	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.77e-05	0.000391	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ABCB1—melanoma	6.45e-05	0.000372	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP17A1—melanoma	6.25e-05	0.000361	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.24e-05	0.00036	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.16e-05	0.000356	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ALB—melanoma	6.16e-05	0.000356	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—melanoma	6.09e-05	0.000351	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PRKCA—melanoma	5.93e-05	0.000342	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GNA11—melanoma	5.9e-05	0.000341	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ERCC2—melanoma	5.89e-05	0.00034	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ABCB1—melanoma	5.82e-05	0.000336	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—melanoma	5.82e-05	0.000336	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ALB—melanoma	5.79e-05	0.000334	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—FASN—melanoma	5.78e-05	0.000333	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NRAS—melanoma	5.75e-05	0.000332	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC5A5—melanoma	5.68e-05	0.000328	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MAPK3—melanoma	5.5e-05	0.000318	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GNAQ—melanoma	5.49e-05	0.000317	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CD44—melanoma	5.49e-05	0.000317	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.37e-05	0.00031	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PRKCA—melanoma	5.35e-05	0.000309	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.32e-05	0.000307	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ERCC2—melanoma	5.31e-05	0.000306	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP1B1—melanoma	5.26e-05	0.000304	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MAPK1—melanoma	5.24e-05	0.000302	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—KRAS—melanoma	4.94e-05	0.000285	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.88e-05	0.000281	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CG—melanoma	4.65e-05	0.000268	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.64e-05	0.000268	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CA—melanoma	4.54e-05	0.000262	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPARG—melanoma	4.49e-05	0.000259	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.4e-05	0.000254	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TP53—melanoma	4.4e-05	0.000254	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ABCB1—melanoma	4.33e-05	0.00025	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HRAS—melanoma	4.2e-05	0.000243	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CG—melanoma	4.19e-05	0.000242	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CD—melanoma	4.09e-05	0.000236	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPARG—melanoma	4.05e-05	0.000234	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ALB—melanoma	4.03e-05	0.000233	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PRKCA—melanoma	3.99e-05	0.00023	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ERCC2—melanoma	3.95e-05	0.000228	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT1—melanoma	3.71e-05	0.000214	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CD—melanoma	3.69e-05	0.000213	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ALB—melanoma	3.64e-05	0.00021	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CB—melanoma	3.56e-05	0.000206	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTGS2—melanoma	3.53e-05	0.000204	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.28e-05	0.000189	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CB—melanoma	3.21e-05	0.000185	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTGS2—melanoma	3.18e-05	0.000184	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CG—melanoma	3.12e-05	0.00018	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTEN—melanoma	3.08e-05	0.000178	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPARG—melanoma	3.01e-05	0.000174	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTEN—melanoma	2.78e-05	0.00016	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CD—melanoma	2.75e-05	0.000158	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ALB—melanoma	2.71e-05	0.000156	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CB—melanoma	2.39e-05	0.000138	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTGS2—melanoma	2.37e-05	0.000137	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CA—melanoma	2.17e-05	0.000125	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTEN—melanoma	2.07e-05	0.000119	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CA—melanoma	1.96e-05	0.000113	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKT1—melanoma	1.77e-05	0.000102	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKT1—melanoma	1.6e-05	9.24e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CA—melanoma	1.46e-05	8.42e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKT1—melanoma	1.19e-05	6.88e-05	CbGpPWpGaD
